Literature DB >> 18941912

Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli.

Philippe G Cammisotto1, Moïse Bendayan.   

Abstract

Adiponectin receptor ADIPOR1 activates the intracellular second messenger AMP-activated protein kinase (AMPK) that participates in the control of the oxidative stress and apoptosis. This study reveals the presence of a functional ADIPOR1 receptor in all the cells of the renal glomeruli. Isolated glomeruli were incubated in vitro with adiponectin and proteins analysed by western blot. Electron microscopy using immunogold labeling was carried out on kidney sections. ADIPOR1 and catalytic AMPK sub-units alpha1 and alpha2 were revealed in normal rat glomeruli and incubation of freshly isolated rat glomeruli with either adiponectin or AICAR led to the activation by phosphorylation of catalytic AMPK. Electron microscopy localized with high resolution these proteins at the plasma membrane of the three glomerular cells, namely the endothelial, the mesangial and the podocyte cells, as well as on Bowman's capsule epithelial cells. It is concluded that glomerular cells express a functional adiponectin receptor ADIPOR1 which, through activation of AMPK, may play important roles in the control of oxidative stress and cell survival within the glomerulus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941912     DOI: 10.1007/s10735-008-9198-6

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  30 in total

1.  Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

Authors:  R B Ceddia; R Somwar; A Maida; X Fang; G Bikopoulos; G Sweeney
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

Review 2.  ACRP30, a new hormone controlling fat and glucose metabolism.

Authors:  Tsu-Shuen Tsao; Harvey F Lodish; Joachim Fruebis
Journal:  Eur J Pharmacol       Date:  2002-04-12       Impact factor: 4.432

Review 3.  Colloidal gold post-embedding immunocytochemistry.

Authors:  M Bendayan
Journal:  Prog Histochem Cytochem       Date:  1995

Review 4.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

5.  Energy-dependent regulation of cell structure by AMP-activated protein kinase.

Authors:  Jun Hee Lee; Hyongjong Koh; Myungjin Kim; Yongsung Kim; Soo Young Lee; Roger E Karess; Sang-Hee Lee; Minho Shong; Jin-Man Kim; Jaeseob Kim; Jongkyeong Chung
Journal:  Nature       Date:  2007-05-07       Impact factor: 49.962

6.  Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors.

Authors:  Carmine Zoccali; Francesca Mallamaci; Vincenzo Panuccio; Giovanni Tripepi; Sebastiano Cutrupi; Saverio Parlongo; Francesco Catalano; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

7.  Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.

Authors:  Koji Ohashi; Hirotsugu Iwatani; Shinji Kihara; Yasuhiko Nakagawa; Noriyuki Komura; Koichi Fujita; Norikazu Maeda; Makoto Nishida; Fumie Katsube; Iichiro Shimomura; Takahito Ito; Tohru Funahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-07-12       Impact factor: 8.311

8.  T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.

Authors:  Christopher Hug; Jin Wang; Naina Shehzeen Ahmad; Jonathan S Bogan; Tsu-Shuen Tsao; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

9.  Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells.

Authors:  In-Ja Park; Jin-Taek Hwang; Young Min Kim; Joohun Ha; Ock Jin Park
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  27 in total

1.  Nicotine, smoking, podocytes, and diabetic nephropathy.

Authors:  Edgar A Jaimes; Ming-Sheng Zhou; Mohammed Siddiqui; Gabriel Rezonzew; Runxia Tian; Surya V Seshan; Alecia N Muwonge; Nicholas J Wong; Evren U Azeloglu; Alessia Fornoni; Sandra Merscher; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2021-01-18

Review 2.  Adiponectin effects on the kidney.

Authors:  Natalie Sweiss; Kumar Sharma
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-09-05       Impact factor: 4.690

3.  AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.

Authors:  Assaad A Eid; Bridget M Ford; Karen Block; Balakuntalam S Kasinath; Yves Gorin; Goutam Ghosh-Choudhury; Jeffrey L Barnes; Hanna E Abboud
Journal:  J Biol Chem       Date:  2010-09-22       Impact factor: 5.157

Review 4.  Role of the energy sensor AMP-activated protein kinase in renal physiology and disease.

Authors:  Kenneth R Hallows; Peter F Mount; Núria M Pastor-Soler; David A Power
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-24

5.  Activation of AMP-activated protein kinase prevents TGF-β1-induced epithelial-mesenchymal transition and myofibroblast activation.

Authors:  Sachin Thakur; Suryavathi Viswanadhapalli; Jeffrey B Kopp; Qian Shi; Jeffrey L Barnes; Karen Block; Yves Gorin; Hanna E Abboud
Journal:  Am J Pathol       Date:  2015-06-10       Impact factor: 4.307

6.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

7.  Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.

Authors:  Mai Sugahara; Shinji Tanaka; Tetsuhiro Tanaka; Hisako Saito; Yu Ishimoto; Takeshi Wakashima; Masatoshi Ueda; Kenji Fukui; Akira Shimizu; Reiko Inagi; Toshimasa Yamauchi; Takashi Kadowaki; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2020-01-29       Impact factor: 10.121

8.  Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling.

Authors:  Ji-Young Choi; Tae-Sun Ha; Hye-Young Park; Hee-Yul Ahn
Journal:  Clin Exp Nephrol       Date:  2012-06-20       Impact factor: 2.801

9.  Inhibition of pannexin-1 channel activity by adiponectin in podocytes: Role of acid ceramidase activation.

Authors:  Guangbi Li; Qinghua Zhang; Jinni Hong; Joseph K Ritter; Pin-Lan Li
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-01       Impact factor: 4.698

10.  Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.

Authors:  Leopoldo Raij; Runxia Tian; Jenny S Wong; John C He; Kirk N Campbell
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.